Clinical Trial Update: Oral Cladribine B-cell Study

View source ↗

Summary

The clinical trial update reports completed results for an oral cladribine B-cell study in multiple sclerosis, with results posted on 2026-02-04. The study asse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• MAVENCLAD (cladribine)

Snippet

Sponsor: Queen Mary University of London | Conditions: Multiple Sclerosis | Status: COMPLETED | Results posted: 2026-02-04